This is the authors' abstract. We don't add key points for this paper.
Abstract—Development of the technology of induced pluripotent stem cells (iPSC) opened new opportunities for studies of the mechanisms of pathogenesis and effective treatment of acute and chronic forms of cerebral pathologies. Here, we review current literature data on the use of the iPSC technology for in vitro modeling of Alzheimer’s disease, search for new pharmacological drugs for its treatment, and modern approaches to neurotransplantation for personalized cellular therapy.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Л. Г. Хаспеков (2019) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: